
DEVELOPING: FDA Reverses Moderna Flu Vaccine Rejection!
DEVELOPING: FDA Reverses Moderna Flu Vaccine Rejection!
The FDA has reversed its initial rejection of Moderna's mRNA flu vaccine, following a formal meeting and proposed changes to the application process. This reversal, driven by Moderna's engagement, allows for a review of the vaccine, potentially offering a new option for seniors by late 2026 if approved. This situation highlights the complex interplay of regulatory processes and the potential impact of political appointees on scientific review.




















AI Experts & Community
Be the first to comment